LOPRIORE VINCENT S (Executive Chairman) purchased 160.0% of their position (10M shares) of HEPION PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $500.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 8/13/2026ACC: 0001493152-26-037489
DirectorOfficer· Executive Chairman
Since Mar 2026
+20M
Net shares
Net buyer
$500.0K
Total acquired
2
Open market trades
2B · 0S
4
Total transactions
20M acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+8M
Price / share
$0.05
Trade value
$400K
% of position
128.0%
8/3/2026
6.25M→14.25M
Common Stock
Indirect
Shares
+2M
Price / share
$0.05
Trade value
$100K
% of position
14.0%
8/3/2026
14.25M→16.25M
Total
Net shares
+10M
Net value
$500K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/3/2026 | P · Purchase | +8M | $0.05 | $400K | 128.0% | 6.25M | 14.25M |
| Common Stock Indirect | 8/3/2026 | P · Purchase | +2M | $0.05 | $100K | 14.0% | 14.25M | 16.25M |
| Total | +10M | $500K | ||||||
Derivative Transactions2
Warrants
Indirect
Converts to
Common Stock
8M shares
Shares
+8M
Strike price
0.06
Held after
8M
Exercisable
—
8/3/2026
Warrants
Indirect
Converts to
Common Stock
2M shares
Shares
+2M
Strike price
0.06
Held after
10M
Exercisable
—
8/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants Indirect | Common Stock8M shares | 8/3/2026 | P · Purchase | +8M | 0.06 | — | 8M |
| Warrants Indirect | Common Stock2M shares | 8/3/2026 | P · Purchase | +2M | 0.06 | — | 10M |